Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

PURPOSE: HLA-mismatched unrelated donor (MMUD) hematopoietic stem-cell transplantation (HSCT) is associated with increased graft-versus-host disease (GVHD) and impaired survival. In reduced-intensity conditioning (RIC), neither ex vivo nor in vivo T-cell depletion (eg, antithymocyte globulin) convin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Koreth, John, Stevenson, Kristen E., Kim, Haesook T., McDonough, Sean M., Bindra, Bhavjot, Armand, Philippe, Ho, Vincent T., Cutler, Corey, Blazar, Bruce R., Antin, Joseph H., Soiffer, Robert J., Ritz, Jerome, Alyea, Edwin P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2012
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434979/
https://ncbi.nlm.nih.gov/pubmed/22869883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.0984
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia